Article
Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide…
eLife · 2017 · Jianneng Li, author Mohammad Alyamani, author Ao Zhang, author Kai-Hsiung Chang, author Michael Berk, author Zhenfei Li, author Ziqi Zhu, author Marianne Petro, author Cristina Magi-Galluzzi, author Mary-Ellen Taplin, author Jorge A Garcia, author Kevin Courtney, author Eric A Klein, author Nima Sharifi, author
Key facts
| Title | Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer |
|---|---|
| First author | Jianneng Li, author Mohammad Alyamani, author Ao Zhang, author Kai-Hsiung Chang, author Michael Berk, author Zhenfei Li, author Ziqi Zhu, author Marianne Petro, author Cristina Magi-Galluzzi, author Mary-Ellen Taplin, author Jorge A Garcia, author Kevin Courtney, author Eric A Klein, author Nima Sharifi, author |
| Journal | eLife |
| Published | Feb 13, 2017 |
| DOI | 10.7554/eLife.20183 |
| Devices mentioned | 008983, K100793 |
| Product codes mentioned | KIE, LLZ |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1